| 1 |
28162002 | Pharmacokinetic drug evaluation of bucindolol for the treatment of atrial fibrillation in heart failure patients. | 2017 Apr |
1 |
| 2 |
24322971 | Cardiovascular pharmacogenomics: expectations and practical benefits. | 2014 Mar |
1 |
| 3 |
24159564 | Prevention of atrial fibrillation by bucindolol is dependent on the beta₁389 Arg/Gly adrenergic receptor polymorphism. | 2013 Aug |
3 |
| 4 |
19880803 | An alpha2C-adrenergic receptor polymorphism alters the norepinephrine-lowering effects and therapeutic response of the beta-blocker bucindolol in chronic heart failure. | 2010 Jan |
1 |